In addition, we found that IRF8 binds and modulates several critical transcriptional regulators, such as RUNX1 and IRF5, which are downstream effectors of many signaling pathways [47,55], implicating a global and sophisticated regulatory function of IRF8 in AML cells. This evidence concerns the gene RUNX1 and acute myeloid leukemia.